BioCep is a biotechnology company that has developed a large-scale, automated immunomagnetic cell isolation technology for the cell and gene therapy market.
A LEAP FORWARD IN MAGNETIC-BASED CELL ISOLATION TECHNOLOGY
BioCep’s flagship product, SmartSepTM, combines four powerful magnetic isolation areas with continuous flow technology, to smartly separate target cells that are attached to magnetic beads, with exceptional rates of recovery, viability and purity. Comprising a large-scale cell isolation instrument with closed, sterile, disposable kits, SmartSepTM also enables an efficient bead removal process before infusion to the patient.
MASTERING CELL ISOLATION TO POWER PERSONALIZED CELL THERAPY PRODUCTION
BioCep’s automated, hands-free system is fully adjustable and can be tailored to different cell manufacturing protocols and applications. Seamlessly integrated within CAR-T and other cell therapy production processes, SmartSepTM directly addresses the growing industry challenge to enable high yields of cell isolation and recovery for autologous and allogeneic cell treatments.
LED BY HIGHLY-EXPERIENCED LIFE-SCIENCE INDUSTRY EXECUTIVES
The leadership team includes acclaimed Israeli life science inventor, Dr. Shmuel Cabilly, whose inventions are used by hundreds of companies worldwide to develop more than 500 drugs .CEO, Uri Yogev, who successfully sold his biotech company, Ethrog Biotechnologies, to the global sector leader.
If you are seeking a superior solution to enhance your cell isolation process, please get in touch.
